REPORT HIGHLIGHT
Transplant Diagnostics Market size was valued at USD 4,809.2 Million in 2022, expanding at a CAGR of 7.6% from 2023 to 2030.
The process of detecting and connecting both the cells and tissues of a donor as well as a recipient in transplant surgery is referred to as transplant diagnostics. It is an important element of the transplant procedure since the mutual compatibility of the donor and recipient is essential for a successful transplant. The purpose of transplant diagnostics is to reduce the possibility of rejection while also ensuring that the transplanted cell or organ works correctly in the recipient's system. The transplant process may begin after the donor and recipient have been matched. Following the transplant, the receiver will be constantly examined to verify that the donated tissue or organ is working well and that no symptoms of rejection exist. Continuous monitoring and testing are important to the transplant's long-term viability.
Transplant Diagnostics Market- Market Dynamics
Rising Number of Organ Failure is Expected To Drive Market Growth
As the incidence of acute illnesses rises, so does the number of organ failures, boosting the need for transplant operations and boosting the transplant diagnostics industry. Organ transplantation is a complicated surgery, and the operation's success is dependent on the recipient's biological system accepting the donor's part. Transplantation diagnostic procedures are used to determine if an organ transplant will be acceptable. In accordance with the United Network for Organ Sharing, a non-profit organization located in the United States that handles organ transplantation in the country, the United States will see a record-breaking number of liver transplants in 2021. In 2021, 24,669 transplants of kidneys, 9,236 transplants of the liver, and 3,817 transplants of the heart were done. The transplant diagnostics industry is being driven by the growing need for diagnostic testing.
Transplant Diagnostics Market- Key Insights
- As per the analysis shared by our research analyst, the global Transplant Diagnostics market is estimated to grow annually at a CAGR of around XX% over the forecast period (2023-2030)
- The Transplant Diagnostics industry is projected to grow at a significant rate due to the rising number of organ failure worldwide.
- Based on technology segmentation, Molecular array segment was predicted to show maximum market share in the year 2022
- Based on product and services, reagents and consumables was predicted to show maximum market share in the year 2022
- Based on end-use segmentation, Hospitals and transplants centers was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Transplant Diagnostics Market- Segmentation Analysis:
The Global Transplant Diagnostics Market is segmented on the basis of Product and Services, End-User, Technology, and Region.
The market is divided into three categories based on Product and Services: Instruments, Software and services, Reagents and consumables. Reagents and consumables dominate the market. The major feature of this market is the greater utilization prevalence of these items throughout all sectors and end-users, as well as higher replacement costs despite the lower costs. Companies of such diagnostic tools are using techniques such as reagents and consumable purchasing contracts. Furthermore, the frequent purchasing of reagents and consumables is a major element in promoting their adoption.
The market is divided into three categories based on End-User: Hospitals and transplants centers, Research laboratories and academic institutes, Commercial service providers. The hospitals and transplant centers dominate the market and are likely to maintain their dominance during the forecast period. Hospitals and transplant centers have grown dramatically, owing to increased demand for transplant commodities that include immunosuppressants, tissue goods, and also organ preservation procedures, as well as technological advancements. Rising incidence of acute diseases which lead to organ failure, as well as transplant businesses concentrating more on trademark security, are two more drivers driving the market growth.
Transplant Diagnostics Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is likely to maintain its dominant position in the transplant diagnostics industry during the projected timeframe. Economies in the area, such as the USA and Canada, have well-funded groups, facilities, and government participation in generating money and awareness to encourage organ transplants for individuals. For example, the National Institute of Health estimates that funding for transplantation studies will be US $ 721 million, US $ 702 million, and US $ 735 million in 2020, 2021, and 2022, correspondingly. Increasing financing for transplantation studies will consequently lead to increased utilization of transplant diagnostics, driving market expansion in this area.
Transplant Diagnostics Market- Competitive Landscape:
The global marketplace is extremely competitive, with just a few competitors fighting against one other. Some of the present possibilities and obstacles that businesses are anticipated to confront throughout the projected duration are advancements in technology concerning reagent efficiency, cost-effectiveness, physician's decision-making, increasing understanding, and adequate organ preservation infrastructure. The limitations of transplant diagnostic procedures such as serology-based as well as PCR-based HLA typing raise the total cost of goods. As a consequence, players are pursuing measures that include long-term agreements with diagnostic facilities and labs, as well as bulk purchasing discounts. Plexision, a biotechnology business established in the United States, has begun international operations by establishing its reference facility in Hyderabad, India. This laboratory will provide a full range of diagnostics for transplant patients. The company's proprietary personalized transplant diagnostic procedures used to predict resistance and viral infections are among these tests, as are medication-level surveillance, pharmacogenomics, and genetic evaluations.
Recent Developments:
In March 2023, Quest Diagnostics, the nation's top supplier of diagnostic imaging offerings, announced the launch of a complete package of advanced diagnostics as well as assistance services aimed at increasing access to laboratory testing for transplanting solid organs, human cells, and tissue.
Key features of the study:
- This proposed research study on Transplant Diagnostics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Transplant Diagnostics market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Transplant Diagnostics market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Transplant Diagnostics market
- Impact of COVID-19 on Transplant Diagnostics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Transplant Diagnostics market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Transplant Diagnostics market, we have also included competitive landscape and key innovator analysis for the Transplant Diagnostics market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Transplant Diagnostics market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Transplant Diagnostics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL TRANSPLANT DIAGNOSTICS MARKET KEY PLAYERS
- Abbott Laboratories, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-LA Roche, Ltd.
- Illumina, Inc.
- Immucor, Inc.
- Linkage Biosciences
- Olerup SSP AB
- Qiagen N.V.
- Sigma-Aldrich
- Thermo Fisher Scientific, Inc.
- Zimmer Biomet
- TransMedics
- Luminex Corporation
- BAG Diagnostics GmbH
- PathoNostics
GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES
- Instruments
- Software and services
- Reagents and consumables
GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END-USER
- Hospitals and transplants centers
- Research laboratories and academic institutes
- Commercial service providers
GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY
- Molecular array
- Non molecular array
GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA